ArticleJACC. CardioOncology2021
Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States.
Article in JACC. CardioOncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.
- Financial Toxicity and Its Determinants in Cardiovascular Diseases: A Systematic Review and Bayesian Meta-Analysis.Inquiry : a journal of medical care organization, provision and financingPooled it
- Review
- Rural-urban disparities in cardiovascular and other competing risk of death among cancer patients.Journal of advanced research · 2026Article
- Financial Toxicity Associated with Biological Medicines: A Scoping Review.Clinical pharmacology and therapeutics · 2026Article
- Food and Nutrition Insecurity in Cancer Survivorship: A Global Scoping Review.Cancer medicine · 2026Article
- Annual Out-of-Pocket Medical Costs and Financial Toxicity Among Transplant Recipients in the United States.Journal of general internal medicine · 2026Article
- Cost and transportation barrier trends related to Affordable Care Act among cancer survivors and atherosclerotic cardiovascular disease patients.PLOS global public health · 2026Article
- Financial toxicity in patients with newly diagnosed hepatocellular carcinoma: a cross-sectional study.Journal of gastrointestinal oncology · 2025Article
- A 10-year comparative analysis of medical and surgical specialty lobbying by physician professional organizations.Health affairs scholar · 2025Article
- Non-monetary burdens of out-of-pocket costs incurred by patients and caregivers for medical care: a scoping review.BMJ open · 2025Article
- Racial and Ethnic Disparities in Cardio-Oncology Care.Current cardiology reports · 2025Review
- Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management.International journal of molecular sciences · 2025Review
- Financial toxicity and psychological distress in cardiovascular non-cancer multimorbidity: a latent profile analysis and causal weighting.Frontiers in psychology · 2025Article
- Chronic illnesses requiring home-based palliative care and their impact on families in an urban resettlement colony of Delhi, India.Palliative care and social practice · 2025Article
- The Financial Impact of Post Intensive Care Syndrome.Critical care clinics · 2025Review
- Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux.Journal of nanobiotechnology · 2024Article
- Understanding and Reducing the Social and Environmental Determinants of Health Disparities in Cardio-Oncology.JACC. CardioOncology · 2024Article
- Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer.JACC. CardioOncology · 2024Article
- Association of cardiovascular risk profile with premature all-cause and cardiovascular mortality in US adults: findings from a national study.BMC cardiovascular disorders · 2024Article
- Comparative analysis of financial toxicity between SARS-CoV-2 infection and common comorbidities.PloS one · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 7 institutions in 1 country.
Funding
Abstract
backgroundFinancial toxicity (FT) is a well-established side-effect of the high costs associated with cancer care. In recent years, studies have suggested that a significant proportion of those with atherosclerotic cardiovascular disease (ASCVD) experience FT and its consequences.
objectivesThis study aimed to compare FT for individuals with neither ASCVD nor cancer, ASCVD only, cancer only, and both ASCVD and cancer.
methodsFrom the National Health Interview Survey, we identified adults with self-reported ASCVD and/or cancer between 2013 and 2018, stratifying results by nonelderly (age <65 years) and elderly (age ≥65 years). We defined FT if any of the following were present: any difficulty paying medical bills, high financial distress, cost-related medication nonadherence, food insecurity, and/or foregone/delayed care due to cost.
resultsThe prevalence of FT was higher among those with ASCVD when compared with cancer (54% vs. 41%; p < 0.001). When studying the individual components of FT, in adjusted analyses, those with ASCVD had higher odds of any difficulty paying medical bills (odds ratio [OR]: 1.22; 95% confidence interval [CI]: 1.09 to 1.36), inability to pay bills (OR: 1.25; 95% CI: 1.04 to 1.50), cost-related medication nonadherence (OR: 1.28; 95% CI: 1.08 to 1.51), food insecurity (OR: 1.39; 95% CI: 1.17 to 1.64), and foregone/delayed care due to cost (OR: 1.17; 95% CI: 1.01 to 1.36). The presence of ≥3 of these factors was significantly higher among those with ASCVD and those with both ASCVD and cancer when compared with those with cancer (23% vs. 30% vs. 13%, respectively; p < 0.001). These results remained similar in the elderly population.
conclusionsOur study highlights that FT is greater among patients with ASCVD compared with those with cancer, with the highest burden among those with both conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.